These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 9591497

  • 1. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.
    Ylikorkala O, Cacciatore B, Paakkari I, Tikkanen MJ, Viinikka L, Toivonen J.
    Fertil Steril; 1998 May; 69(5):883-8. PubMed ID: 9591497
    [Abstract] [Full Text] [Related]

  • 2. Different effects of oral and transdermal hormonal replacement on prostacyclin and thromboxane A2.
    Viinikka L, Orpana A, Puolakka J, Pyörälä T, Ylikorkala O.
    Obstet Gynecol; 1997 Jan; 89(1):104-7. PubMed ID: 8990448
    [Abstract] [Full Text] [Related]

  • 3. Administration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells.
    Mikkola T, Viinikka L, Ylikorkala O.
    Fertil Steril; 2000 Jan; 73(1):72-4. PubMed ID: 10632415
    [Abstract] [Full Text] [Related]

  • 4. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels.
    Eviö S, Tiitinen A, Turpeinen U, Ylikorkala O.
    Fertil Steril; 2000 Dec; 74(6):1080-3. PubMed ID: 11119731
    [Abstract] [Full Text] [Related]

  • 5. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
    Laivuori H, Koistinen HA, Karonen SL, Cacciatore B, Ylikorkala O.
    Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954
    [Abstract] [Full Text] [Related]

  • 6. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G, Ozmen B, Erguder I.
    Maturitas; 2006 Jan 10; 53(1):32-8. PubMed ID: 16325022
    [Abstract] [Full Text] [Related]

  • 7. Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy.
    Saltevo J, Puolakka J, Ylikorkala O.
    Diabetes Obes Metab; 2000 Oct 10; 2(5):293-8. PubMed ID: 11225744
    [Abstract] [Full Text] [Related]

  • 8. Effects of norethisterone acetate addition to estradiol in long term HRT.
    Li C, Samsioe G, Wilaman K, Lidfelt J, Nerbrand C, Agardh CD, Schersten B.
    Maturitas; 2000 Aug 31; 36(2):139-52. PubMed ID: 11006501
    [Abstract] [Full Text] [Related]

  • 9. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
    Yilmazer M, Fenkci V, Fenkci S, Sonmezer M, Aktepe O, Altindis M, Kurtay G.
    Maturitas; 2003 Dec 10; 46(4):245-53. PubMed ID: 14625121
    [Abstract] [Full Text] [Related]

  • 10. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
    Taşçı T, Şükür YE, Özmen B, Atabekoğlu CS, Cengiz SD, Koçbulut E, Berker B, Sönmezer M.
    Eur J Obstet Gynecol Reprod Biol; 2014 May 10; 176():50-4. PubMed ID: 24655552
    [Abstract] [Full Text] [Related]

  • 11. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
    Taskinen MR, Puolakka J, Pyörälä T, Luotola H, Bjäörn M, Kääriänen J, Lahdenperä S, Ehnholm C.
    Arterioscler Thromb Vasc Biol; 1996 Oct 10; 16(10):1215-21. PubMed ID: 8857916
    [Abstract] [Full Text] [Related]

  • 12. Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations.
    Mattsson LA, Bohnet HG, Gredmark T, Torhorst J, Hornig F, Hüls G.
    Obstet Gynecol; 1999 Jul 10; 94(1):61-5. PubMed ID: 10389719
    [Abstract] [Full Text] [Related]

  • 13. Effect of sequential estrogen/progestin treatment on biochemical vasoactive markers in postmenopausal women comparing oral and transdermal application.
    Seeger H, Mueck AO, Teichmann AT, Lippert TH.
    Clin Exp Obstet Gynecol; 2000 Jul 10; 27(1):17-20. PubMed ID: 10758791
    [Abstract] [Full Text] [Related]

  • 14. Hormone replacement therapy modifies the capacity of plasma and serum to regulate prostacyclin and endothelin-1 production in human vascular endothelial cells.
    Mikkola T, Ranta V, Orpana A, Viinikka L, Ylikorkala O.
    Fertil Steril; 1996 Sep 10; 66(3):389-93. PubMed ID: 8751735
    [Abstract] [Full Text] [Related]

  • 15. Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis.
    Christodoulakos G, Panoulis C, Kouskouni E, Chondros C, Dendrinos S, Creatsas G.
    Gynecol Endocrinol; 2002 Feb 10; 16(1):9-17. PubMed ID: 11915588
    [Abstract] [Full Text] [Related]

  • 16. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S, Ylikorkala O, Arrenbrecht S.
    Int J Fertil Womens Med; 1997 Feb 10; 42 Suppl 2():376-87. PubMed ID: 9397385
    [Abstract] [Full Text] [Related]

  • 17. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E, Holinka CF, Arrenbrecht S.
    Int J Fertil Womens Med; 1997 Feb 10; 42 Suppl 2():388-98. PubMed ID: 9397386
    [Abstract] [Full Text] [Related]

  • 18. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study.
    Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK.
    Hypertension; 1995 Apr 10; 25(4 Pt 2):848-53. PubMed ID: 7721443
    [Abstract] [Full Text] [Related]

  • 19. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Fertil Steril; 2001 Mar 10; 75(3):554-9. PubMed ID: 11239541
    [Abstract] [Full Text] [Related]

  • 20. The values of urinary NTx in postmenopausal women undergoing HRT; the role of additional alendronate therapy.
    Posaci C, Altunyurt S, Islekel H, Saygili U, Altekin E, Onvural A, Onvural B.
    Maturitas; 2002 Aug 30; 42(4):281-6. PubMed ID: 12191850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.